A novel drug combination and route for COVID-19 treatment
Not Applicable
- Conditions
- Corona virus
- Registration Number
- PACTR202101875903773
- Lead Sponsor
- Hazem Elsersy
- Brief Summary
Not available
- Detailed Description
Not available
Recruitment & Eligibility
- Status
- Complete
- Sex
- All
- Target Recruitment
- 200
Inclusion Criteria
COVID-19 PCR positive patients of both genders aging 6 to 70 years having no symptoms or early symptoms such as loss of taste and smell, fever, cough with good O2 saturation.
Exclusion Criteria
Patients with CT evidence category 4 or 5.
Patients with dropped O2 saturation below 90 on room air.
Patients with uncontrolled hypertension or diabetes mellitus.
Ventilated patients or those with multiorgan failure.
Study & Design
- Study Type
- Interventional
- Study Design
- Not specified
- Primary Outcome Measures
Name Time Method The primary outcome will be the PCR result for corona virus on day 4 and day 10. This will be done for the early treatment experiment;number of treated close contacts getting infected with corona virus in both groups
- Secondary Outcome Measures
Name Time Method The post-treatment day that the fever subsides; the post-treatment day for return of taste and smell ;The post-treatment day that the cough subsides;Number of patients needed hospitalization.;the number of deaths in both groups